The Shareholders Foundation announces that an investor, who purchased shares of IsoRay, Inc. (NYSEMKT:ISR), filed a lawsuit in the U.S. District Court for the Central District of California over alleged violations of Federal Securities Laws by IsoRay, Inc.
Investors who purchased shares of IsoRay, Inc. (NYSEMKT:ISR) have certain options and for certain investors are short and strict deadlines running. Deadline: July 21, 2015. NYSEMKT:ISR investors should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 – 1554.
According to the complaint the plaintiff alleges on behalf of purchasers of IsoRay, Inc. (NYSEMKT:ISR) common shares between May 20, 2015 and May 21, 2015, that the defendants violated Federal Securities Laws. More specifically, the plaintiff claims that Defendants allegedly made false and/or misleading statements regarding IsoRay’s Celsium-131 isotope seeds and mesh for the treatment of non-small cell lung cancers and that when the true details entered the market, shares of IsoRay, Inc. (NYSEMKT:ISR) fell $1.10 per share or over 35% to close at $2.02 per share on May 21, 2015, damaging investors.
On May 20, 2015, IsoRay, Inc. announced the on-line publication of the first major peer reviewed study showing improved results using IsoRay’s Cesium-131 seeds in the treatment of lung cancer.
Shares of IsoRay, Inc. (NYSEMKT:ISR) grew from $1.48 per sahare on May 19, 2015, to as high as $3.79 per share on May 21, 2015.
However, on May 21, 2015, an article was published that said that “IsoRay does a poor job selling radioactive ‘seeds’ for use in cancer radiation therapy” and “to make up for the inability to deliver revenue growth — and prop up its stock price”
Shares of IsoRay, Inc. (NYSEMKT:ISR) closed on May 21, 2015 at $2.02 per share.
Those who purchased shares of IsoRay, Inc. (NYSEMKT:ISR) have certain options and should contact the Shareholders Foundation.
Contact:
Shareholders Foundation, Inc.
Michael Daniels
3111 Camino Del Rio North – Suite 423
92108 San Diego
Phone: +1-(858)-779-1554
Fax: +1-(858)-605-5739
mail@shareholdersfoundation.com